skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.0.1

Opposition

Number:91252811Filing Date:12/10/2019
Status:PendingStatus Date:12/10/2019
General Contact Number:571-272-8500
Interlocutory Attorney:ASHLEY D HAYES
Paralegal Name:LALITA R WEBB
Defendant
Name:Eagle Sleep Products, LLC
Correspondence:PHILIP ROSENBACH
BERMAN ROSENBACH PC
10 MADISON AVENUE
MORRISTOWN, NJ 07960
UNITED STATES
pr@brglaw.com
Phone: 973-206-8200
 
Serial #:88577036Application FileAssignment
Application Status: Opposition Pending
Mark: Z ZBD
Plaintiff
Name:CVB Inc.
Correspondence:RITA E KLINE
ULMER & BERNE LLP
500 WEST MADISON STREET, SUITE 3600
CHICAGO, IL 60661-4587
UNITED STATES
rkline@ulmer.com, hmaynard@ulmer.com cjmiller@ulmer.com mrink@ulmer.com
Phone: 312-658-6558
 
Serial #:85047970Application FileAssignmentRegistration #:4296941
Application Status: Section 8 and 15 - Accepted and Acknowledged
Mark: Z
 
Serial #:86256105Application FileAssignmentRegistration #:4701371
Application Status: Section 8 and 15 - Accepted and Acknowledged
Mark: Z
 
Serial #:88371704Application FileAssignment
Application Status: Final Refusal - Mailed
Mark: CBD SLEEP
Prosecution History
#DateHistory TextDue Date
1611/06/2020P APPEARANCE / POWER OF ATTORNEY
1510/07/2020PROCEEDINGS RESUMED
1410/05/2020P APPEARANCE / POWER OF ATTORNEY
1310/01/2020RESPONSE DUE 30 DAYS (DUE DATE)10/31/2020
1209/26/2020P REQ TO W/DRAW AS ATTORNEY
1109/26/2020P REQ TO W/DRAW AS ATTORNEY
1008/27/2020EXTENSION OF TIME GRANTED
908/27/2020P MOT FOR EXT W/ CONSENT
807/29/2020EXTENSION OF TIME GRANTED
707/29/2020P MOT FOR EXT W/ CONSENT
606/11/2020EXTENSION OF TIME GRANTED
506/11/2020P MOT FOR EXT W/ CONSENT
401/17/2020ANSWER
312/10/2019INSTITUTED
212/10/2019NOTICE AND TRIAL DATES SENT; ANSWER DUE:01/19/2020
112/10/2019FILED AND FEE
Results as of 03/08/2021 08:59 AM
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY